(Q47396348)

15 January 2018

title

Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective? (English)

1 reference

15 January 2018

0 references

1 reference

J E Roeters van Lennep

1

1 reference

15 January 2018

E Meijer

2

1 reference

15 January 2018

F J C M Klumper

3

1 reference

15 January 2018

J M Middeldorp

4

1 reference

15 January 2018

K W M Bloemenkamp

5

1 reference

15 January 2018

S Middeldorp

6

1 reference

15 January 2018

publication date

1 March 2011

1 reference

15 January 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

15 January 2018

volume

9

1 reference

15 January 2018

issue

3

1 reference

15 January 2018

page(s)

473-480

1 reference

15 January 2018

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

High rate of skin complications due to low-molecular-weight heparins in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Low-molecular-weight heparin in pregnancy: peripartum bleeding complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

The safety of low molecular weight heparin therapy during labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Prophylactic and therapeutic enoxaparin during pregnancy: indications, outcomes and monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04186.X

10.1111/J.1538-7836.2011.04186.X

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018